Tetsuro Otsuka - Concepedia

Author

Tetsuro Otsuka

Also Known As

Tetsuro Otsuka

Publications

356

Citations

H-Index

Concepts

All Affiliations

Tetsuro Otsuka is an author at Astellas Pharma (Japan) specializing in hemodialysis, immunohematology, and clinical trials.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	103
2	Medicine	1	1	103
3	Clinical Nutrition	1	1	103
4	Nephrology	1	1	103
5	Clinical Trials	1	1	103

Tetsuro Otsuka

Publications

345

Citations

H-Index

Page 1

	Year	Citations
Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study Tadao Akizawa, Tetsuro Otsuka, Michael Reusch, Therapeutic Apheresis and Dialysis ImmunohematologyDialysisRenal PathologyDialysis TherapyPharmacotherapy	2019	103
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, Advances in Therapy	2019	83
A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis Tadao Akizawa, Yusuke Yamaguchi, Tetsuro Otsuka, The Nephron journals/Nephron journals	2020	63
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, Kidney International Reports	2021	62
Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients Tadao Akizawa, Keiko Tanaka‐Amino, Tetsuro Otsuka, American Journal of Nephrology	2021	23
Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat Tadao Akizawa, Keiko Tanaka‐Amino, Tetsuro Otsuka, Clinical and Experimental Nephrology	2022	11

Page 1